Natrecor (nesiritide), a new IV drug for treating patients who are hospitalized with acute CHF.

You'll soon see patients on Natrecor (nesiritide), a new IV drug for treating patients who are hospitalized with acute CHF.

It's in a new drug class...human B-type natriuretic peptide (hBNP).

Natrecor is a recombinant version of this peptide...and has vasodilatory and diuretic effects.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote